1. All potential registrants,
downstream users and third parties who have submitted information to the
Agency in accordance with Article
28, or whose information is held by the
Agency in accordance with Article
15, for the same phase-in substance, or registrants who have submitted a
registration for that phase-in substance before the deadline set out in Article
23(3), shall be participants in a substance information exchange forum (SIEF).
2. The aim of each SIEF shall be to:
(a) facilitate, for the purposes of
registration, the exchange of the information specified in Article
10(a) (vi) and (vii) between potential registrants, thereby avoiding the duplication of
studies; and
(b) agree classification and labelling where there is a difference in the classification and labelling of the substance between
potential registrants.
3. SIEF participants shall provide other participants with existing
studies, react to requests by other participants for information, collectively identify needs for further
studies for the purposes of paragraph 2(a) and arrange for such
studies to be carried out. Each SIEF shall be operational until 1 June 2018.